Found: 30
Select item for more details and to access through your institution.
Author's reply: The relationship between systemic inflammation and liver fibrogenesis in patients with cirrhosis.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 520, doi. 10.1111/liv.15507
- By:
- Publication type:
- Article
Trends in prevalence of probable fibrotic non‐alcoholic steatohepatitis in the United States, 1999–2016.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 340, doi. 10.1111/liv.15503
- By:
- Publication type:
- Article
Long‐term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 413, doi. 10.1111/liv.15497
- By:
- Publication type:
- Article
Muscle strength in non‐alcoholic fatty liver disease and all‐cause and cause‐specific mortality.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 513, doi. 10.1111/liv.15498
- By:
- Publication type:
- Article
Different methodologies of protein induced by vitamin K absence or antagonist II in patients without hepatocellular carcinoma.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 518, doi. 10.1111/liv.15496
- By:
- Publication type:
- Article
Difficulties for providing evidence in hepatocellular carcinoma with Child‐Pugh B liver function.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 274, doi. 10.1111/liv.15495
- By:
- Publication type:
- Article
The combination of ALBI and AFP response: A small step forward in HCC.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 271, doi. 10.1111/liv.15494
- By:
- Publication type:
- Article
A SEC61A1 variant is associated with autosomal dominant polycystic liver disease.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 401, doi. 10.1111/liv.15493
- By:
- Publication type:
- Article
Organophosphate pesticides: Another silent liver hazard?
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 268, doi. 10.1111/liv.15492
- By:
- Publication type:
- Article
Extracellular vesicles in fatty liver disease and steatohepatitis: Role as biomarkers and therapeutic targets.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 292, doi. 10.1111/liv.15490
- By:
- Publication type:
- Article
Lower frequency of MDSCs was significantly related to functional cure in CHB patients treated with peginterferon.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 329, doi. 10.1111/liv.15489
- By:
- Publication type:
- Article
Colonization with multidrug‐resistant organisms is associated with impaired survival of patients with surgically resected cholangiocarcinoma.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 490, doi. 10.1111/liv.15485
- By:
- Publication type:
- Article
Biglycan promotes hepatic fibrosis through activating heat shock protein 47.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 500, doi. 10.1111/liv.15477
- By:
- Publication type:
- Article
LINC01608 activated by YY1 facilitate hepatocellular carcinoma progression by modulating the EGFR/ERK axis.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 471, doi. 10.1111/liv.15479
- By:
- Publication type:
- Article
Letter to the Editor regarding "Long‐term exposure to air pollution and incident non‐alcoholic fatty liver disease and cirrhosis".
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 517, doi. 10.1111/liv.15472
- By:
- Publication type:
- Article
Multiple arterial‐phase MRI with gadoxetic acid improves diagnosis of hepatocellular carcinoma ≤3.0 cm.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 462, doi. 10.1111/liv.15470
- By:
- Publication type:
- Article
High prevalence of lower limb atherosclerosis is linked with the gut–liver axis in patients with primary biliary cholangitis.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 370, doi. 10.1111/liv.15463
- By:
- Publication type:
- Article
Securing wider EU commitment to the elimination of hepatitis C virus.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 276, doi. 10.1111/liv.15446
- By:
- Publication type:
- Article
Severe maternal–fetal pathological damage and inflammatory responses contribute to miscarriage caused by hepatitis E viral infection during pregnancy.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 317, doi. 10.1111/liv.15468
- By:
- Publication type:
- Article
Confidence in treatment is contributing to quality of life in autoimmune liver diseases. The results of ERN RARE‐LIVER online survey.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 381, doi. 10.1111/liv.15440
- By:
- Publication type:
- Article
Effect of cumulative body mass index exposure and long‐term related change on incident non‐alcoholic fatty liver disease.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 345, doi. 10.1111/liv.15436
- By:
- Publication type:
- Article
CCN6 improves hepatic steatosis, inflammation, and fibrosis in non‐alcoholic steatohepatitis.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 357, doi. 10.1111/liv.15430
- By:
- Publication type:
- Article
Quality of end‐of‐life care with non‐malignant liver disease: Analysis of the VOICES National Survey of Bereaved People.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 308, doi. 10.1111/liv.15428
- By:
- Publication type:
- Article
Analysis of the humoral and cellular response after the thirdCOVID‐19 vaccination in patients with autoimmune hepatitis.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 393, doi. 10.1111/liv.15368
- By:
- Publication type:
- Article
APASL‐ACLF Research Consortium–Artificial Intelligence (AARC‐AI) model precisely predicts outcomes in acute‐on‐chronic liver failure patients.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 442, doi. 10.1111/liv.15361
- By:
- Publication type:
- Article
Long‐term exposure to air pollution and incident non‐alcoholic fatty liver disease and cirrhosis: A cohort study.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 299, doi. 10.1111/liv.15416
- By:
- Publication type:
- Article
Immunogenicity and safety of a third dose of anti‐SARS‐CoV‐2 BNT16b2 vaccine in liver transplant recipients.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 452, doi. 10.1111/liv.15331
- By:
- Publication type:
- Article
Incidence and outcomes of thromboembolic and bleeding events in patients with liver cirrhosis in the USA.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 434, doi. 10.1111/liv.15325
- By:
- Publication type:
- Article
High plasma levels of betaine, a trimethylamine N‐Oxide‐related metabolite, are associated with the severity of cirrhosis.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 424, doi. 10.1111/liv.15310
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 263, doi. 10.1111/liv.15299
- Publication type:
- Article